SLOUGH, England and RICHMOND, Va., Jan. 4, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that Shaun Thaxter, CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference on January 11th, 2018, at 8:30 a.m. local Pacific time (11:30 a.m. Eastern / 4:30 p.m. GMT) from the Westin St. Francis Hotel in San Francisco. Mark Crossley, CFO, and Jason Thompson, VP of Investor Relations, will also be in attendance. Thaxter will review Indivior's business and outlook. The presentation will be webcast live and, along with the presentation materials, will be available to the public on the "Investors" section of Indivior's website (www.indivior.com).
About Indivior
Indivior is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy while providing education on evidence-based treatment models that have revolutionized modern addiction treatment. The name is the fusion of the words individual and endeavour, and the tagline "Focus on you" makes the Company's commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 900 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more.
SOURCE Indivior PLC